iCrowdNewswire Jan 21, 2021 6:00 PM ET
The cardiac tumor is an abnormal growth of tissues in the heart or heart valves. Cardiac tumors are rare and can be cancerous or noncancerous. Tumors that originate in the heart and are bound to stay there are called primary tumors. On the contrary, tumors that grow in some other part of the body and spreads to the heart i.e. metastasize are called secondary tumors. Most cardiac tumors are benign, but even these tumors can create problems due to their size and location
The prevalence of primary cardiac tumors is 0.001-0.03%. Secondary tumors are 20-40 found to be more common than primary tumors because 15% of patients with any form of cancer exhibit metastases to the heart. According to the WHO, cancer is the leading cause of death worldwide, accounting for 8.8 million deaths in 2015. Globally, lung cancer accounted for 1.69 million deaths and subsequently, breast cancer caused 571,000 deaths in 2015.
Cardiac neoplasm is a rare pathological condition associated with non-specific signs and symptoms and must be considered while treating conditions like cardiac arrhythmia, ischemic syndromes, and Hiss-Purkinje conduction system dysfunction. Sometimes drugs can be injected into the pericardial area of the heart to slow the tumor growth.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/5065
The heart tumor market is segmented on the basis of type, diagnosis, treatment.
On the basis of the type, the market is segmented into the primary tumor and secondary tumor. The primary tumors are divided into benign and malignant. The benign tumor is further categorized into myxoma, papillary heart tumors, fibromas, rhabdomyomas, angioma, and lipomas.
On the basis of diagnosis, the market is classified into Echocardiogram, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Radionuclide imaging, Positron Emission Tomography (PET) Scan, myocardial biopsy, cardiac catheterization, electrophysiology test.
On the basis of the treatment, the market is classified as surgery, chemotherapy, radiation therapy. Furthermore, the surgery is further categorized into open heart surgery, minimally invasive surgery, and heart transplant surgery
Access Full Report Summary @https://www.marketresearchfuture.com/reports/heart-tumor-market-5065
Some of key the players in the global heart tumor market are Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporation, Pie Medical Imaging, HeartSciences, 3mensio Medical Imaging, and eMedica, S.L.
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.
Market Research Future
Office No. 528, Amanora Chambers
Pune – 411028
Phone: +1 646 845 9312
Keywords: Heart Tumor Market, Heart Tumor, Heart Tumor Market Size, Heart Tumor Market Share, Heart Tumor Market Growth, Heart Tumor Market Trends